Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P S Anderson

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Journal of Medicinal Chemistry|March 1, 1983
Synthesis of (7R)-7H-indolo[3,4-gh][1,4]benzoxazines, a new class of D-heteroergolines with dopamine agonist activityP S Anderson, J J Baldwin, D E McClure, et al.
Journal of Medicinal Chemistry|October 1, 1979
Synthesis, assignment of absolute configuration, and receptor binding studies relevant to the neuroleptic activities of a series of chiral 3-substituted cyproheptadine atropisomersW C Randall, P S Anderson, E L Cresson, et al.
Antimicrobial Agents and Chemotherapy|December 3, 1999
Expanded-spectrum nonnucleoside reverse transcriptase inhibitors inhibit clinically relevant mutant variants of human immunodeficiency virus type 1J W Corbett, S S Ko, J D Rodgers, et al.
Journal of Medicinal Chemistry|August 1, 1977
Synthesis and stereospecific antipsychotic activity of (-)-1-cyclopropylmethyl-4-(3-trifluoromethylthio-5H-dibenzo[a,d]cyclohepten-5-ylidene)piperidineD C Remy, K E Rittle, C A Hunt, et al.
Journal of Medicinal Chemistry|July 1, 1983
Synthesis and receptor binding studies relevant to the neuroleptic activities of some 1-methyl-4-piperidylidene-9-substituted-pyrrolo[2,1-b][3]benzazepine derivativesD C Remy, S F Britcher, S W King, et al.
Journal of Medicinal Chemistry|May 23, 2000
Inhibition of clinically relevant mutant variants of HIV-1 by quinazolinone non-nucleoside reverse transcriptase inhibitorsJ W Corbett, S S Ko, J D Rodgers, et al.
Journal of Medicinal Chemistry|March 1, 1982
Inhibitors of gastric acid secretion: 3,4-diamino-1,2,5-thiadiazole 1-oxides and 1,1-dioxides as urea equivalents in a series of histamine H2-receptor antagonistsW C Lumma, P S Anderson, J J Baldwin, et al.
Journal of Cardiovascular Pharmacology|August 13, 1998
Oral antiplatelet efficacy and specificity of a novel nonpeptide platelet GPIIb/IIIa receptor antagonist, DMP 802S A Mousa, R E Olson, J M Bozarth, et al.
Chemistry & Biology|November 18, 1998
Design and selection of DMP 850 and DMP 851: the next generation of cyclic urea HIV protease inhibitorsJ D Rodgers, P Y Lam, B L Johnson, et al.
Journal of Medicinal Chemistry|April 10, 1999
Orally active isoxazoline glycoprotein IIb/IIIa antagonists with extended duration of actionR E Olson, T M Sielecki, J Wityak, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Journal of Medicinal Chemistry|March 1, 1983
Synthesis of (7R)-7H-indolo[3,4-gh][1,4]benzoxazines, a new class of D-heteroergolines with dopamine agonist activityP S Anderson, J J Baldwin, D E McClure, et al.
Journal of Medicinal Chemistry|October 1, 1979
Synthesis, assignment of absolute configuration, and receptor binding studies relevant to the neuroleptic activities of a series of chiral 3-substituted cyproheptadine atropisomersW C Randall, P S Anderson, E L Cresson, et al.
Antimicrobial Agents and Chemotherapy|December 3, 1999
Expanded-spectrum nonnucleoside reverse transcriptase inhibitors inhibit clinically relevant mutant variants of human immunodeficiency virus type 1J W Corbett, S S Ko, J D Rodgers, et al.
Journal of Medicinal Chemistry|August 1, 1977
Synthesis and stereospecific antipsychotic activity of (-)-1-cyclopropylmethyl-4-(3-trifluoromethylthio-5H-dibenzo[a,d]cyclohepten-5-ylidene)piperidineD C Remy, K E Rittle, C A Hunt, et al.
Journal of Medicinal Chemistry|July 1, 1983
Synthesis and receptor binding studies relevant to the neuroleptic activities of some 1-methyl-4-piperidylidene-9-substituted-pyrrolo[2,1-b][3]benzazepine derivativesD C Remy, S F Britcher, S W King, et al.
Journal of Medicinal Chemistry|May 23, 2000
Inhibition of clinically relevant mutant variants of HIV-1 by quinazolinone non-nucleoside reverse transcriptase inhibitorsJ W Corbett, S S Ko, J D Rodgers, et al.
Journal of Medicinal Chemistry|March 1, 1982
Inhibitors of gastric acid secretion: 3,4-diamino-1,2,5-thiadiazole 1-oxides and 1,1-dioxides as urea equivalents in a series of histamine H2-receptor antagonistsW C Lumma, P S Anderson, J J Baldwin, et al.
Journal of Cardiovascular Pharmacology|August 13, 1998
Oral antiplatelet efficacy and specificity of a novel nonpeptide platelet GPIIb/IIIa receptor antagonist, DMP 802S A Mousa, R E Olson, J M Bozarth, et al.
Chemistry & Biology|November 18, 1998
Design and selection of DMP 850 and DMP 851: the next generation of cyclic urea HIV protease inhibitorsJ D Rodgers, P Y Lam, B L Johnson, et al.
Journal of Medicinal Chemistry|April 10, 1999
Orally active isoxazoline glycoprotein IIb/IIIa antagonists with extended duration of actionR E Olson, T M Sielecki, J Wityak, et al.
Pageof 9